<DOC>
	<DOCNO>NCT00205179</DOCNO>
	<brief_summary>The purpose pilot study evaluate potential effect soy isoflavone supplement cognitive function men woman Alzheimer 's Disease ( AD ) . Preliminary study evaluate effect soy supplement memory cognitively healthy old adult yield promising result evaluate patient AD . It hypothesize isoflavone supplement ameliorate cognitive decline older adult diagnose Alzheimer 's disease , compare subject placebo .</brief_summary>
	<brief_title>Alzheimer 's Disease : Potential Benefit Isoflavones</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Diagnosis probable AD Has reliable available caregiver assist medication appointment On stable dose cholinesterase inhibitor , unable tolerate medication , patient plan reinitiate cholinergic therapy study Current recent use ( &lt; 6 month ) menopausal HRT Current recent use ( &lt; 4 month ) oral antibiotic therapy Typical dietary intake soy isoflavones &gt; 5 mg/day History significant gastrointestinal colon disease , colon/intestinal resection Irritable bowel syndrome History breast cancer , abnormal mammogram within 12 month History chronic obstructive pulmonary disease , diabetes mellitus , liver disease unstable ischemic heart disease Significant neurological disease AD might affect cognitive function , stroke , Parkinson 's disease , multiple sclerosis , serious traumatic brain injury</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>